rate-limiting and regulated enzyme (1-4). The first mammalian CT was purified from rat liver (5, 6), and the corresponding CTa cDNA was cloned and expressed (7).
Phosphatidylcholine (PC)
1 is the major membrane phospholipid in mammalian cells and tissues. PC is made in all nucleated cells via the CDP-choline pathway in which CTP:phosphocholine cytidylyltransferase (CT) is recognized as an important rate-limiting and regulated enzyme (1) (2) (3) (4) . The first mammalian CT was purified from rat liver (5, 6) , and the corresponding CTa cDNA was cloned and expressed (7) .
CTa is ubiquitous and the most active form of CT (8, 9) although cDNAs for two other isoenzymes, CTß1 (8) and its splice variant CTß2 (9) , were recently cloned, and are encoded by a second gene. All isoforms contain a highly conserved catalytic domain and a helical lipid-binding domain (8) . CTa and CTß2 contain a highly phosphorylated domain at their carboxyl termini (1-4, 9-11), while CTß1 lacks this domain (8) . The functions of the individual domains for regulation of CTa activity have been extensively studied. The helical domain for the binding of specific lipids
(1-4, 12, 13), and a highly phosphorylated domain at the carboxyl terminus (1-4, 11, [14] [15] [16] [17] , are important for the modulation of CTa activity. However, less is known about the regulation or function of CTß1 and CTß2. Zhang et al. showed that CTß2 is induced in macrophages from CTa-deficient mice and a low level of CTß2 activity is apparently enough to keep the cells viable (18) .
In addition to post-translational regulation, CTa mRNA levels have been reported to be regulated transcriptionally and post-transcriptionally. Tessner et al. (19) provided the first evidence for increased CT mRNA in colony stimulating factor 1-stimulated macrophages. Houweling et al. (20) demonstrated that C T a i s regulated at the level of its mRNA in rat liver after partial hepatectomy. The maximal increase in the CTa mRNA coincided with maximal DNA synthesis 24 h after partial hepatectomy (21) . CTa is highly expressed during the perinatal period and the regulated post-transcriptionally, apparently by reduction in the rate of mRNA degradation (19, 25) . However, the precise mechanisms involved in regulating CT mRNA stability still have to be elucidated. Chinese hamster ovary cells and alveolar type II epithelial cells were cultured in lipoprotein-deficient serum, respectively. However, the physiological importance of this sterol response site in transcriptional regulation of the CTa gene is not clear (35) .
In this study, we provide evidence that Ets-1 is a major transcription factor involved in the basal transcription of the CTa gene. Ets-1 was first reported as a proto-oncogene for avian erythroblastosis (36) . 
, and 5' -CAGGTACCAGGGCGGGCGGGAGGCGGGACT-3', respectively, and GL Primer 2 (Promega) as a universal reverse primer from the luciferase vector. The amplified fragments were purified, cut with KpnI/HindIII and cloned into the corresponding site of the pGL3-basic vector. Fig. 1 shows the partial structure of the mouse Ctpct promoter from -212 to +38, and indicates the start positions of the deletion mutants.
When we searched the CTa promoter region by TRANSFAC transcription factor database, several important consensus elements for the binding of transcription factors were identified (Fig. 1 
Construction of TEF-4 and Ets-1 Expression Vectors-

Preparation of Nuclear Extracts and Electromobility Gel-shift Assays-Nuclear
extracts from COS-7 cells were prepared according to Andrews and Faller (37) with minor modifications (27). Five hundred pmol of the opposite strands of pEts (5'- (Tokyo, Japan)). The intensity of the gel-shift band was calculated using the Quantity
One software (PDI, Huntington Station, NY). To substantiate this proposal we made mutated constructs of LUC.C7 and LUC.D1.5 at each putative transcription factor binding site shown in Fig. 1 . After transfection, the luciferase activities of the mutated LUC.C7 and LUC.D1.5
SDS-PAGE and Immunoblot Analysis-
RESULTS
Deletion and Mutation Analysis of Chimeric CTa Promoter-Luciferase Reporters and Their Activation by TEF-4 in COS-7 Cells-
constructs were assayed ( Fig. 2B and 2C , respectively). When the Sp1 site at -139
was mutated, the luciferase activity of the LUC.mSp1(1)/C7 was decreased significantly, but only 25% compared with LUC.C7. When the Sp1 site at -67 was mutated, the luciferase activities of LUC.mSp1(2)/C7 did not decrease compared to LUC.C7. The luciferase activity of the NF-kB site mutant (LUC.mNF-kB/C7) decreased by 25% compared to LUC.C7 (Fig. 2B) . Mutation in the CREBP binding site at +20 slightly decreased the luciferase activity ( Fig. 2A, B, and C) .
DNA Binding Properties of the Nuclear Extracts of COS-7 Cells-To test whether
or not there is a protein in the nuclear extracts from COS-7 cells that binds to the putative EBS (-49/-47), we prepared probes with or without a mutation in the EBS.
As shown in Fig. 3A , lanes 2 and 3, DNA-protein complexes with the pEts (-65/-36)
probe were clearly identified. When the EBS in pEts was mutated from GACTTC to ACCAAA (-53/-48) (pmEts-a) (Fig. 3A, lanes 7 and 8) or from TCC to AAA (-49/-47) (pmEts-b) (Fig. 3A, lanes 10 and 11) , the bands were attenuated or disappeared.
These results strongly suggested that there was a protein(s) in the extracts of COS-7 cells that bound to EBS in the pEts probe.
After transfection with pcTEF-4, the band intensities of the specific DNA-protein complexes were significantly increased (Fig. 3A , lane 2 and 3, and Fig. 3B ). This result indicated that TEF-4 enhanced the binding of pEts probe and protein complexes to EBS. antibody in the nuclear extracts from COS-7 cells (Fig. 4A, upper panel) . When various amounts of the anti-Ets-1/Ets-2 antibody were added to incubations of nuclear extracts with the pEts probe, the intensity of the immunoreactive band decreased (Fig. 4B, left) . This result indicated that the bands revealed by the gelshift analysis resulted from a complex of Ets-1 or Ets-2 with the pEts probe. To determine which member of the Ets family was binding to pEts, we used an Ets-1 specific antibody. Immunoblot analysis showed a 54-kDa protein that cross-reacted with anti-Ets-1 antibody in the nuclear extracts from COS-7 cells (Fig. 4A, middle panel). When we used the anti-Ets-1 antibody with the probe in gel shift analyses, the decrease in the intensity of the band was similar to anti-Ets-1/-2 ( Fig. 4B, right) .
Identification of Ets-1 as the Protein that Binds to the pEts Probe-
Thus, it appears that Ets-1 is the protein that binds to the EBS of pEts.
When COS-7cells were stimulated with TEF-4, the basal luciferase activities of LUC.C7 and LUC.D1.5 were increased (Fig. 2) and the binding of endogenous Ets-1 to pEts was significantly enhanced (Fig. 3, lane 3) . However, immunoblot analysis showed that the amount of Ets-1, or actin as the internal standard, was not changed by TEF-4 stimulation (Fig. 4A) . Thus, TEF-4 might modify the binding of Ets-1 to the promoter, and enhance Ets-1-stimulated CTa transcription.
Over-expression of Ets-1 Increases the Binding of Ets to the CTa promoter-In
another approach to confirm that Ets does indeed bind to the CTa promoter, we transfected COS-7 cells with a vector that contained the cDNA encoding Ets-1 (pcEts-1) or the vector alone (pcDNA). Nuclear extracts were prepared after 48 h and incubated with labeled pEts probe (Fig. 5A ). There was increased binding of a nuclear protein to the probe in extracts from cells transfected with pcEts-1 (lane 3)
compared to pcDNA (lane 2). Evidence that this nuclear protein was Ets was
provided by incubation of the nuclear extract with antibody to Ets-1 (anti-V5) and a super shift was observed (Fig. 5A, lane 5) . (24), in colony stimulating factor 1-stimulated macrophages (19) , after partial hepatectomy (20, 21) , and during the perinatal period (22) . Moreover, CTa expression is enhanced in tumorigenic cells (56) (57) (58) .
Expression of Ets-1 and TEF-4 Enhance the Expression of the mRNA for
Ets-1 may be expressed in cells and tissues in proliferative situations, then enhance the induction of CTa mRNA in preparation for cell growth. 
